Extracellular danger-associated molecular patterns signal to NOD-like receptors, but the exact signalling pathways remain unclear. The inflammasomes, a subgroup of these receptors, translate danger signals into inflammatory responses by maturing IL-1 and IL-18. In 2017, researchers reported novel functions of the mutual interaction between metabolism and the inflammasomes in health and disease.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
O'Neill, L. A. et al. A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 16, 553–565 (2016).
Hotamisligil, G. S. Inflammation, metaflammation and immunometabolic disorders. Nature 542, 177–185 (2017).
Camell, C. et al. Regulation of Nlrp3 inflammasome by dietary metabolites. Semin. Immunol. 27, 334–342 (2015).
Schroder, K. et al. The NLRP3 inflammasome: a sensor for metabolic danger? Science 327, 296–300 (2010).
Próchnicki, T. & Latz, E. Inflammasomes on the crossroads of innate immune recognition and metabolic control. Cell Metab. 26, 71–93 (2017).
Mandrup-Poulsen, T. IAPP boosts islet macrophage IL-1 in Type 2 diabetes. Nat. Immunol. 11, 881–883 (2010).
Dror, E. et al. Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation. Nat. Immunol. 18, 283–292 (2017).
Camell, C. D. et al. Inflammasome-driven catecholamine catabolism in macrophages blunts lipolysis during ageing. Nature 550, 119–123 (2017).
Furman, D. et al. Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states. Nat. Med. 23, 174–184 (2017).
Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119–1131 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Mandrup-Poulsen, T. Metabolism and the inflammasome in health and ageing. Nat Rev Endocrinol 14, 72–74 (2018). https://doi.org/10.1038/nrendo.2017.175
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2017.175
This article is cited by
-
Rolle der Metaflammation als systemische Manifestation bei Stoffwechselerkrankungen
Die Innere Medizin (2023)
-
Immunometabolism and HIV-1 pathogenesis: food for thought
Nature Reviews Immunology (2021)
-
Treatment of type 2 diabetes by targeting interleukin-1: a meta-analysis of 2921 patients
Seminars in Immunopathology (2019)